Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole

M. A. Ghannoum, B. J. Spellberg, A. S. Ibrahim, J. A. Ritchie, B. Currie, E. D. Spitzer, J. E. Edwards, A. Casadevall

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Analysis of the sterol compositions of 13 clinical isolates of the pathogenic yeast Cryptococcus neoformans obtained from five patients with recurring cryptococcal meningitis showed that, unlike Candida albicans, the major sterols synthesized by this yeast were obtusifoliol (range, 21.1 to 68.2%) and ergosterol (range, 0.0 to 46.5%). There was considerable variation in the sterol contents among the 13 isolates, with total sterol contents ranging from 0.31 to 5.9% of dry weight. The isolates from the five patients who had relapses had different total sterol contents and compositions in comparison with those of the pretreatment isolates, indicating either that the sterols had been changed by therapy or that the patients were infected with new isolates with different sterol compositions. Growth of the cryptococcal isolates in the presence of subinhibitory concentrations of fluconazole (0.25x the MIC) significantly altered the sterol content and pattern. The total sterol content decreased in nine isolates and increased in four isolates in response to pretreatment with fluconazole. Fluconazole had no consistent effect on ergosterol levels. In contrast, fluconazole caused a decrease in obtusifoliol levels and an increase in 4,14-dimethylzymosterol levels in all isolates. These results indicate extensive diversity in sterol content, sterol composition, and sterol synthesis in response to subinhibitory concentrations of fluconazole in C. neoformans strains. We propose that fluconazole inhibits the sterol synthesis of C. neoformans by interfering with both 14α-demethylase-dependent and -independent pathways. No correlation between the sterol compositions of C. neoformans isolates and their susceptibilities to fluconazole was found.

Original languageEnglish (US)
Pages (from-to)2029-2033
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume38
Issue number9
StatePublished - 1994
Externally publishedYes

Fingerprint

Cryptococcus neoformans
Fluconazole
Sterols
Ergosterol
Yeasts
Cryptococcal Meningitis
Candida albicans

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Ghannoum, M. A., Spellberg, B. J., Ibrahim, A. S., Ritchie, J. A., Currie, B., Spitzer, E. D., ... Casadevall, A. (1994). Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrobial Agents and Chemotherapy, 38(9), 2029-2033.

Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. / Ghannoum, M. A.; Spellberg, B. J.; Ibrahim, A. S.; Ritchie, J. A.; Currie, B.; Spitzer, E. D.; Edwards, J. E.; Casadevall, A.

In: Antimicrobial Agents and Chemotherapy, Vol. 38, No. 9, 1994, p. 2029-2033.

Research output: Contribution to journalArticle

Ghannoum, MA, Spellberg, BJ, Ibrahim, AS, Ritchie, JA, Currie, B, Spitzer, ED, Edwards, JE & Casadevall, A 1994, 'Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole', Antimicrobial Agents and Chemotherapy, vol. 38, no. 9, pp. 2029-2033.
Ghannoum MA, Spellberg BJ, Ibrahim AS, Ritchie JA, Currie B, Spitzer ED et al. Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. Antimicrobial Agents and Chemotherapy. 1994;38(9):2029-2033.
Ghannoum, M. A. ; Spellberg, B. J. ; Ibrahim, A. S. ; Ritchie, J. A. ; Currie, B. ; Spitzer, E. D. ; Edwards, J. E. ; Casadevall, A. / Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole. In: Antimicrobial Agents and Chemotherapy. 1994 ; Vol. 38, No. 9. pp. 2029-2033.
@article{7cd88b06c63940579e9db55ac20595b8,
title = "Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole",
abstract = "Analysis of the sterol compositions of 13 clinical isolates of the pathogenic yeast Cryptococcus neoformans obtained from five patients with recurring cryptococcal meningitis showed that, unlike Candida albicans, the major sterols synthesized by this yeast were obtusifoliol (range, 21.1 to 68.2{\%}) and ergosterol (range, 0.0 to 46.5{\%}). There was considerable variation in the sterol contents among the 13 isolates, with total sterol contents ranging from 0.31 to 5.9{\%} of dry weight. The isolates from the five patients who had relapses had different total sterol contents and compositions in comparison with those of the pretreatment isolates, indicating either that the sterols had been changed by therapy or that the patients were infected with new isolates with different sterol compositions. Growth of the cryptococcal isolates in the presence of subinhibitory concentrations of fluconazole (0.25x the MIC) significantly altered the sterol content and pattern. The total sterol content decreased in nine isolates and increased in four isolates in response to pretreatment with fluconazole. Fluconazole had no consistent effect on ergosterol levels. In contrast, fluconazole caused a decrease in obtusifoliol levels and an increase in 4,14-dimethylzymosterol levels in all isolates. These results indicate extensive diversity in sterol content, sterol composition, and sterol synthesis in response to subinhibitory concentrations of fluconazole in C. neoformans strains. We propose that fluconazole inhibits the sterol synthesis of C. neoformans by interfering with both 14α-demethylase-dependent and -independent pathways. No correlation between the sterol compositions of C. neoformans isolates and their susceptibilities to fluconazole was found.",
author = "Ghannoum, {M. A.} and Spellberg, {B. J.} and Ibrahim, {A. S.} and Ritchie, {J. A.} and B. Currie and Spitzer, {E. D.} and Edwards, {J. E.} and A. Casadevall",
year = "1994",
language = "English (US)",
volume = "38",
pages = "2029--2033",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole

AU - Ghannoum, M. A.

AU - Spellberg, B. J.

AU - Ibrahim, A. S.

AU - Ritchie, J. A.

AU - Currie, B.

AU - Spitzer, E. D.

AU - Edwards, J. E.

AU - Casadevall, A.

PY - 1994

Y1 - 1994

N2 - Analysis of the sterol compositions of 13 clinical isolates of the pathogenic yeast Cryptococcus neoformans obtained from five patients with recurring cryptococcal meningitis showed that, unlike Candida albicans, the major sterols synthesized by this yeast were obtusifoliol (range, 21.1 to 68.2%) and ergosterol (range, 0.0 to 46.5%). There was considerable variation in the sterol contents among the 13 isolates, with total sterol contents ranging from 0.31 to 5.9% of dry weight. The isolates from the five patients who had relapses had different total sterol contents and compositions in comparison with those of the pretreatment isolates, indicating either that the sterols had been changed by therapy or that the patients were infected with new isolates with different sterol compositions. Growth of the cryptococcal isolates in the presence of subinhibitory concentrations of fluconazole (0.25x the MIC) significantly altered the sterol content and pattern. The total sterol content decreased in nine isolates and increased in four isolates in response to pretreatment with fluconazole. Fluconazole had no consistent effect on ergosterol levels. In contrast, fluconazole caused a decrease in obtusifoliol levels and an increase in 4,14-dimethylzymosterol levels in all isolates. These results indicate extensive diversity in sterol content, sterol composition, and sterol synthesis in response to subinhibitory concentrations of fluconazole in C. neoformans strains. We propose that fluconazole inhibits the sterol synthesis of C. neoformans by interfering with both 14α-demethylase-dependent and -independent pathways. No correlation between the sterol compositions of C. neoformans isolates and their susceptibilities to fluconazole was found.

AB - Analysis of the sterol compositions of 13 clinical isolates of the pathogenic yeast Cryptococcus neoformans obtained from five patients with recurring cryptococcal meningitis showed that, unlike Candida albicans, the major sterols synthesized by this yeast were obtusifoliol (range, 21.1 to 68.2%) and ergosterol (range, 0.0 to 46.5%). There was considerable variation in the sterol contents among the 13 isolates, with total sterol contents ranging from 0.31 to 5.9% of dry weight. The isolates from the five patients who had relapses had different total sterol contents and compositions in comparison with those of the pretreatment isolates, indicating either that the sterols had been changed by therapy or that the patients were infected with new isolates with different sterol compositions. Growth of the cryptococcal isolates in the presence of subinhibitory concentrations of fluconazole (0.25x the MIC) significantly altered the sterol content and pattern. The total sterol content decreased in nine isolates and increased in four isolates in response to pretreatment with fluconazole. Fluconazole had no consistent effect on ergosterol levels. In contrast, fluconazole caused a decrease in obtusifoliol levels and an increase in 4,14-dimethylzymosterol levels in all isolates. These results indicate extensive diversity in sterol content, sterol composition, and sterol synthesis in response to subinhibitory concentrations of fluconazole in C. neoformans strains. We propose that fluconazole inhibits the sterol synthesis of C. neoformans by interfering with both 14α-demethylase-dependent and -independent pathways. No correlation between the sterol compositions of C. neoformans isolates and their susceptibilities to fluconazole was found.

UR - http://www.scopus.com/inward/record.url?scp=0028067397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028067397&partnerID=8YFLogxK

M3 - Article

C2 - 7811014

AN - SCOPUS:0028067397

VL - 38

SP - 2029

EP - 2033

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -